89bio’s Phase 2b ENLIVEN Trial of Pegozafermin in Nonalcoholic Steatohepatitis (NASH) Achieved High Statistical Significance on Both Primary Histology Endpoints with Weekly (QW) and Every-Two-Week (Q2W) Dosing at 24 Weeks – Yahoo Finance March 22, 2023
Monkeypox Vaccine Plan Prods Cities and States to Adopt New Dosing Regimen August 19, 2022August 18, 2022
Covid: Arkansas jail dosing inmates with ivermectin in spite of FDA warnings | Coronavirus August 26, 2021August 26, 2021